| Tag | Content |
|---|
EnhancerAtlas ID | HS034-29837 |
Organism | Homo sapiens |
Tissue/cell | ECC-1 |
Coordinate | chr8:131218280-131219210 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EHF | MA0598.2 | chr8:131218927-131218939 | TACTTCCGGGTG | - | 6.62 | | ELF3 | MA0640.1 | chr8:131218926-131218939 | ATACTTCCGGGTG | - | 6.32 | | ELF4 | MA0641.1 | chr8:131218927-131218939 | TACTTCCGGGTG | - | 6.07 | | ELF5 | MA0136.2 | chr8:131218927-131218938 | TACTTCCGGGT | - | 6.62 | | RUNX3 | MA0684.1 | chr8:131219084-131219094 | TTTGCGGTTT | - | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09147 | chr8:131202941-131227373 | CD14 | | SE_45598 | chr8:131218037-131222056 | Osteoblasts |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH08I130205 | chr8 | 131218047 | 131220245 |
|
Enhancer Sequence | TCTCAAATTT TTATAATAAA TATGTATGAT TTTTTAAATA GAAGGAGTTA AAAATAAACC 60
TTTCCCTCTT ACCCACCCAC CAACCCACAT GGATAGATCA CATTTCACAA AATGTCCCAC 120
AGTATTAATT GGTAGTGAGG CAGTGAGGCA TGTCAGGAAA TAAGGGGATA CCTGGTAGAT 180
CAAACGCTGA AAACTGCCAA TGATTGATGA CCATTTTTTT AAAAGATAAG GTTTTAAAAA 240
TGCATTATAT AGTTCAGGGC ACCCAGAAGC TACCAATTTT ACCATTAGGC ACATCCATGC 300
TCTCCATACT TTTTAACATT TCAAAGAAGA ACTTGAGAAA TAATCTGCTG GCTACAAATC 360
TAGATCCAAC CTGTACATTA TCAGATATTC TTATTTGAGG GGAAAGAAAA GAAGAAAAAT 420
AAAAAAAAAA ACAACTTTAA CACAAACCAC AATACCCTAC AGTCAGAGAT TGCAAACAGG 480
AAATGCTATG CAGATGGAGA AATCTTTGCT TTGCTTCAAC AGCTCTGAAG CAATAACTGC 540
CCTCCAACTG TTTAATGAGA CTCAAGCTCT TATGCAAGCT ATAGAATTGT CCAAAGGCCT 600
CCGGAGAGAA GAAACCAGAT GCATGGTGAG TCCTGGCTGA CCTAGAATAC TTCCGGGTGA 660
CTCCCACTAT TTAAAAAATA ATTTATATAC ATTTTCTAAA ACCATTGCTG CCTTGGGACT 720
TTCAAAGGGT ATGGCATTTA AATGGTTTTC CTCTGTCCAT TGAGAATCTA TTTCAATCCA 780
CCAGTTATTC CTTTCCTGAC CCATTTTGCG GTTTTGGTAT TAAATGGATG CAAATCTCTG 840
CTGACTCCTT AACTTCTTTG CTAGGATCAC AGGAATGATG CCTGATGCCA GGAGTAGAGC 900
AGACCCAGCA TTGCTTAGCA AGTAATGATT 930
|
